Literature DB >> 28505487

Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.

Shannon R Kenney1, Genie L Bailey2, Bradley J Anderson3, Michael D Stein4.   

Abstract

OBJECTIVE: An individual's self-efficacy to refuse using heroin in high-risk situations is believed to minimize the likelihood for relapse. However, among individuals completing inpatient heroin detoxification, perceived refusal self-efficacy may also reduce one's perceived need for medication-assisted treatment (MAT), an effective and recommended treatment for opioid use disorder. In the current study, we examined the relationship between heroin refusal self-efficacy and preference for MAT following inpatient detoxification.
METHOD: Participants (N=397) were interviewed at the start of brief inpatient opioid detoxification. Multiple logistic regression was used to estimate the adjusted association of background characteristics, depressed mood, and perceived heroin refusal self-efficacy with preference for MAT.
RESULTS: Controlling for other covariates, depressed mood and lower perceived refusal self-efficacy were associated with a significantly greater likelihood of expressing preference for MAT (versus no MAT).
CONCLUSIONS: Perceived ability to refuse heroin after leaving detox is inversely associated with a heroin user's desire for MAT. An effective continuum of care model may benefit from greater attention to patient's perceived refusal self-efficacy during detoxification which may impact preference for MAT and long-term recovery.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Heroin dependence; Medication-assisted treatment; Opioid detoxification; Refusal self-efficacy

Mesh:

Year:  2017        PMID: 28505487      PMCID: PMC5510548          DOI: 10.1016/j.addbeh.2017.05.009

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  29 in total

1.  Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.

Authors:  Alexander M Ponizovsky; Alexander Grinshpoon; Anatoly Margolis; Rami Cohen; Paula Rosca
Journal:  Addict Behav       Date:  2006-03-09       Impact factor: 3.913

2.  Willpower versus "skillpower": Examining how self-efficacy works in treatment for marijuana dependence.

Authors:  Mark D Litt; Ronald M Kadden
Journal:  Psychol Addict Behav       Date:  2015-05-04

3.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

4.  Effects of brief cognitive-behavioral interventions on confidence to resist the urges to use heroin and methamphetamine in relapse-related situations.

Authors:  Cheng-Fang Yen; Hsiao-Yen Wu; Ju-Yu Yen; Chih-Hung Ko
Journal:  J Nerv Ment Dis       Date:  2004-11       Impact factor: 2.254

5.  Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.

Authors:  Maree Teesson; Alys Havard; Sandra Fairbairn; Joanne Ross; Michael Lynskey; Shane Darke
Journal:  Drug Alcohol Depend       Date:  2005-06-01       Impact factor: 4.492

6.  Overdose after detoxification: a prospective study.

Authors:  James D Wines; Richard Saitz; Nicholas J Horton; Christine Lloyd-Travaglini; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

7.  Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine.

Authors:  Darius A Rastegar; Sarah Sharfstein Kawasaki; Van L King; Elizabeth E Harris; Robert K Brooner
Journal:  Subst Use Misuse       Date:  2016-04-20       Impact factor: 2.164

8.  Craving and self-efficacy in the first five weeks of methadone maintenance therapy: a daily process study.

Authors:  William D Barta; Megan E Kurth; Michael D Stein; Howard Tennen; Susan M Kiene
Journal:  J Stud Alcohol Drugs       Date:  2009-09       Impact factor: 2.582

9.  Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.

Authors:  Lisa A Uebelacker; Genie Bailey; Debra Herman; Bradley Anderson; Michael Stein
Journal:  J Subst Abuse Treat       Date:  2016-03-09

10.  Risk factors for criminal recidivism - a prospective follow-up study in prisoners with substance abuse.

Authors:  Anders Håkansson; Mats Berglund
Journal:  BMC Psychiatry       Date:  2012-08-15       Impact factor: 3.630

View more
  3 in total

Review 1.  A Scoping Review of Drug Epidemic Models.

Authors:  Wei Wang; Sifen Lu; Haoxiang Tang; Biao Wang; Caiping Sun; Pai Zheng; Yi Bai; Zuhong Lu; Yulin Kang
Journal:  Int J Environ Res Public Health       Date:  2022-02-11       Impact factor: 3.390

2.  Negative affect-associated drug refusal self-efficacy, illicit opioid use, and medication use following short-term inpatient opioid withdrawal management.

Authors:  Jumi Hayaki; Micah T Conti; Genie L Bailey; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Subst Abuse Treat       Date:  2021-01-27

3.  Poly-victimization and opioid use during late adolescence and young adulthood: Health behavior disparities and protective factors.

Authors:  Jordan P Davis; Joan S Tucker; Michael Dunbar; Rachana Seelam; Elizabeth J D'Amico
Journal:  Psychol Addict Behav       Date:  2021-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.